Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Nov 19, 2017
|Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study
Journal of the American Academy of Dermatology | Nov 05, 2017